NEWS

MEDIA

MEPSGEN plans to IPO in 2025

MEPSGEN plans to IPO in 2025

2023-09-27

MEPS-AMS is the answer to the rapid advancement of MPS

MEPS-AMS is the answer to the rapid advancement of MPS

2023-09-26

MEPSGEN's expertise in both MPS and nanoparticle technologies

MEPSGEN's expertise in both MPS and nanoparticle technologies

2023-09-25

Korea should kick off national-level project to end animal-testing

Korea should kick off national-level project to end animal-testing

2023-09-19

South Korea's national assembly must pass the VAAM act to become a first mover

South Korea's national assembly must pass the VAAM act to become a first mover

2023-09-18

MEPSGEN's MPS chip will lead the global drug evaluation platform market

MEPSGEN's MPS chip will lead the global drug evaluation platform market

2023-09-08

To network with amazing people at KAATC

To network with amazing people at KAATC

2023-09-07

Which non-clinical platform will fill the gap?

Which non-clinical platform will fill the gap?

2023-08-09

CEO YongTae Kim shares his thoughts on how blood-brain-barrier-on-a-chip could improve the drug development process

CEO YongTae Kim shares his thoughts on how blood-brain-barrier-on-a-chip could improve the drug development process

2023-08-02

Mepsgen targets CRO business with its scalable microphysiological system solution

Mepsgen targets CRO business with its scalable microphysiological system solution

2023-07-18

[BIOPLUS-INTERPHEX (BIX) KOREA 2023] Mepsgen attends BIX

[BIOPLUS-INTERPHEX (BIX) KOREA 2023] Mepsgen attends BIX

2023-07-11

New Research Paper titled "Manufactured Tissue-to-Tissue Barrier Chip for Modeling the Human Blood-Brain Barrier and Regulation of Cellular Trafficking."

New Research Paper titled "Manufactured Tissue-to-Tissue Barrier Chip for Modeling the Human Blood-Brain Barrier and Regulation of Cellular Trafficking."

2023-06-30

[Bio TV] Get an inside look at the mind of CEO YongTae Kim!

[Bio TV] Get an inside look at the mind of CEO YongTae Kim!

2023-06-27

[2023 MPS World Summit] MEPSGEN's participation in 2023 MPS World Summit

[2023 MPS World Summit] MEPSGEN's participation in 2023 MPS World Summit

2023-06-23

[CVB 2023] MEPSGEN's participation in CVB2023

[CVB 2023] MEPSGEN's participation in CVB2023

2023-06-16

Exclusive interview with Dr. Robert Langer, founder of Moderna, and YongTae Kim, CEO of Mepsgen, leading domestic MPS (microphysiological systems) Innovator.

Exclusive interview with Dr. Robert Langer, founder of Moderna, and YongTae Kim, CEO of Mepsgen, leading domestic MPS (microphysiological systems) Innovator.

2023-06-09

Dr. Robert Langer Engages in Discussion with MEPSGEN CEO YongTae Kim on the "Strength and Potential of K-Biotech" at Bio USA 2023 Satellite Event KBTP 2023

Dr. Robert Langer Engages in Discussion with MEPSGEN CEO YongTae Kim on the "Strength and Potential of K-Biotech" at Bio USA 2023 Satellite Event KBTP 2023

2023-06-08

Company Presentation at Bio International Convention 2023_MEPSGEN

Company Presentation at Bio International Convention 2023_MEPSGEN

2023-06-07

K-Bio 544 Companies Converge in Boston, USA... Accelerating Global Expansion.

K-Bio 544 Companies Converge in Boston, USA... Accelerating Global Expansion.

2023-06-07

[BIO International Convention 2023] Come visit us at Booth #2464 (The Korea Pavilion)

[BIO International Convention 2023] Come visit us at Booth #2464 (The Korea Pavilion)

2023-06-05

Sitemap닫기

PRODUCT
MEPS-X
MST-X
PIPELINE
MG-X
TECHNOLOGY
MICROPHYSIOLOGICAL SYSTEMS (MPS)
MICROVORTEX SYSTEM
NANOMEDICINE
SERVICE
SERVICE
ABOUT
OVERVIEW
VISION
HISTORY
ORGANIZATION
CI
OVERSEAS
CONTACT
NEWS
NOTICE
MEDIA
ARTICLE
CAREERS
CULTURE
HIRING
PROCESS
WE'RE HIRING!